CIMETIDINE INJECTION
(HCL) B.P.
COMPOSITION:
Each ampoule contains 200 mg Cimetidine per 2 mL.
PHARMACOLOGICAL ACTION:
Cimetidine is a histamine H-receptor antagonist. Its main action is to inhibit gastric acid secretion. It also inhibits
competitively the other actions of histamine mediated by H-receptors. The decrease in gastric acid secretion occurs
regardless of the nature of the physiological stimulus to secretion, ie. bassal or unstimulated scrction, is reduced. Both
the volume of secretion and the concentration of acid in the secretion are reduced.
INDICATIONS:
The treatment of benign gastric and duodenal uleers, reflux oesophagitis, llingerEllison syndrome and in other
conditions associated with gastric hypersecretory states, such as systermic mastocytosis and multiple endocrine
adenomas. It is also indicated at reduced dosage for duodenal ulcer recurrence in selected patients.
STORAGE INSTRUCTIONS:
Store in a cool place below 25%C. Protect from light
SHELF VALIDITY:
3 years
KEEP OUT OF REACH OF CHILDREN.
Audited Supplier 
){kind=link}